Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Kidney Int. 2006 Oct;70(7):1200-1.

Specific molecular targeting of renal injury in obstructive nephropathy.

Author information

  • Department of Pediatrics, University of Virginia, Charlottesville, Virginia 22908, USA. RLC2M@virginia.edu


Progression of most renal disease involves tubulointerstitial injury, characterized by tubular atrophy, inflammatory cell infiltration, and interstitial fibrosis. Transforming growth factor-beta1 is central in this process. As reported by Moon et al., molecular targeting of the transforming growth factor-beta1 signaling pathway can markedly suppress renal injury resulting from unilateral ureteral obstruction, an established model of obstructive nephropathy. Specific kinase inhibitors are promising therapeutic agents to slow or attenuate progressive renal fibrosis.

Comment on

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk